# S9 Nonclinical Evaluation for Anticancer Pharmaceuticals--Questions and Answers - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/s9-nonclinical-evaluation-for-anticancer-pharmaceuticals-questions-and-answers/5b838cf4-2c2e-4c10-8a24-439ce4ce61f1

> FDA guidance document: S9 Nonclinical Evaluation for Anticancer Pharmaceuticals--Questions and Answers. Issue date: March 08, 2010. Get complete insights and analysis.

---

## Details

- Title: S9 Nonclinical Evaluation for Anticancer Pharmaceuticals--Questions and Answers
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2010-03-08
- Comment Close Date: 2016-11-16
- Last Changed: 2020-04-24
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2009-D-0006">FDA-2009-D-0006</a>

## Related Documents

- [Adaptive Design Clinical Trials for Drugs and Biologics Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/adaptive-design-clinical-trials-for-drugs-and-biologics-guidance-for-industry/97c6b6e1-4164-4fbe-8059-b0aa3fd39415)
- [E17 General Principles for Planning and Design of Multi-Regional Clinical Trials](https://www.globalkeysolutions.net/guidances/guidance-document/e17-general-principles-for-planning-and-design-of-multi-regional-clinical-trials/d2fa5bee-ac83-491d-99ad-7c4d046de439)
- [Labeling for Biosimilar Products Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/labeling-for-biosimilar-products-guidance-for-industry/e13343b3-e9e8-436e-9bcc-ec73cae4d41c)